APO 019 (Cimetidine 300 mg)
Pill imprint APO 019 has been identified as Cimetidine 300 mg.
Cimetidine is used in the treatment of human papilloma virus; gerd; obesity; erosive esophagitis; duodenal ulcer (and more), and belongs to the drug class H2 antagonists. There is no proven risk in humans during pregnancy. Cimetidine 300 mg is not a controlled substance under the Controlled Substance Act (CSA).
- Imprint:
- APO 019
- Strength:
- 300 mg
- Color:
- Green
- Shape:
- Round
- Availability:
- Rx and/or OTC
- Drug Class:
- H2 antagonists
- Pregnancy Category:
- B - No proven risk in humans
- CSA Schedule:
- Not a controlled drug
- Manufacturer:
- Apotex Corp.
- National Drug Code (NDC):
- 60505-0019
| NDC Code | Manufacturer / Repackager |
|---|---|
| 33358-0077 | CorePharma, LLC (repackager) |
| 21695-0531 | Rebel Distributors Corp (repackager) |
| 66336-0944 | Dispensing Solutions Inc. (repackager) |
Note: Inactive ingredients may vary.
More about cimetidine
Consumer resources
- Other brands: Tagamet, Tagamet HB
Professional resources
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
